Europe Stem Cell Manufacturing Market – Industry Trends and Forecast to 2028

  • Medical Devices
  • Published Report
  • Aug 2021
  • Europe
  • 350 Pages
  • No of Tables: 186
  • No of Figures: 36

Europe Stem Cell Manufacturing Market, By Products (Stem Cell Lines, Instruments, Consumables & Kits), Application (Research Applications, Clinical Applications, Cell and Tissue Banking and Others),End User (Biotechnology & Pharmaceutical Companies, Research Institutes and Academic Institutes, Cell Banks and Tissue Banks, Hospital & Surgical Centers and Others), Distribution Channel (Direct Sales and Third Party Distributor), Country (Germany, France, U.K., Italy, Spain, Russia, Belgium, Turkey, Switzerland, Netherlands, and Rest of Europe ) Industry Trends and Forecast to 2028.   

Europe Stem Cell Manufacturing Market Market Analysis and Insights: Europe Stem Cell Manufacturing Market

Europe stem cell manufacturing market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 10.1% in the forecast period of 2021 to 2028 and is expected to reach USD 23,505.08 million by 2028 from USD 11,076.78 million in 2020. The rising prevalence of cancer and stem cell transplant, growth of novel technological advancements for stem cell transplant is likely to be the major drivers which propel the demand of the market in the forecast period.

Stem cells are body’s raw material which can differentiate into variety of cells. It means cells from which all other cells with specialized functions are generated. Stem Cell therapies are defined as treatment for medical condition which involves the use of any type of human stem cells including embryonic stem cells, adult stem cells for allogenic and autologous therapies.

The advent of stem cell research revealed the therapeutic potential of stem cells and derivatives. The successful manufacturing of stem cells and their derivatives is giving positive impact in healthcare arena. These stem cell products are used to restore the function of damaged tissue and organ and to develop stem cell based cellular therapies for the treatment of cancer, haematological disorder, genetic disorder, autoimmune and inflammatory diseases.

Increasing research & development by key industry players for development of innovative products, support by government, and growing adoption of stem cells are driving the growth of the market. Advanced methodologies present in the field are also propelling the growth of the global stem cell manufacturing market. However, high cost of therapies, availability of alterntives for tumor treatment may restrain the market. The presence of large number of pipelines products along with strategic initiatives taken by market players are acting as opportunity for the market. Lack of skilled professional may act as challenge for the market.

The global stem cell manufacturing market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.

Europe Stem Cell Manufacturing Market Stem Cell Manufacturing Market Scope and Market Size

The stem cell manufacturing market is categorized into four notable segments which are based on products, application, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of products, stem cell manufacturing market is segmented into stem cell lines, instruments, consumables & kits. In 2021, consumables & kits segment is expected to dominate the market due to the frequent purchase of consumables, rising stem cell research, and increasing demand for stem cell therapies
  • On the basis of application, cell manufacturing market is segmented into research applications, clinical applications, cell and tissue banking and others. In 2021, research applications segment is expected to dominate market because due to the rising focus on stem cell cytology & pathophysiology research, and growing public-private funding to support stem cell product development and commercialization.
  • On the basis of end user, stem cell manufacturing market is segmented into biotechnology & pharmaceutical companies, research institutes and academic institutes, cell banks and tissue banks, hospital & surgical centers and others. In 2021, pharmaceutical & biotechnology companies segment is expected to dominate the market due to the growing emphasis on strategic initiatives (such as acquisitions, partnerships, and collaborations) by pharma and biotech companies to expand their capabilities in stem cell research.
  • On the basis of distribution channel, stem cell manufacturing market is segmented into direct sales and third party distributors. In 2021, direct sales segment is expected to dominate the market because of large number of players in the market.

Europe Stem Cell Manufacturing Market Country Level Analysis

The stem cell manufacturing market is analysed and market size information is provided by products, application, end user and distribution channel.

The countries covered in the North Ammerica stem cell manufacturing market report are Germany, France, U.K., Italy, Spain, Russia, Belgium, Turkey, Switzerland, Netherlands, and Rest of Europe.

Germany is dominating the global stem cell manufacturing market in the Europe region due to presence of untapped opportunities in Germany for stem cell based products and increased prevalence cases of cancer in Germany.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

The Growing Adoption of Stem Cell Therapy along with Public-Private Funding are Creating Opportunities in the Stem Cell Manufacturing Market  

The stem cell manufacturing market also provides you with detailed market analysis for every country growth in particular industry with wound debridement device sales, impact of advancement in the ELISpot and FluorSpot assayand changes in regulatory scenarios with their support for the ELISpot and FluorSpot assay market. The data is available for historic period 2019 to 2020.

Competitive Landscape and Europe Stem Cell Manufacturing Market Share Analysis

Europe stem cell manufacturing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the stem cell manufacturing market.

The major companies providing the stem cell manufacturing are Thermo Fisher Scientific Inc., Merck KGaA, BD, Organogenesis Inc., Vericel Corporation, ANTEROGEN. CO., LTD., VistaGen Therapeutics, Inc., FUJIFILM Cellular Dynamics, Inc., American CryoSystem Corporation, PromoCell GmbH, Sartorius AG, ViaCyte, Inc., STEM CELL Technologies, Inc., Takeda Pharmaceutical Company Limited, DAIICHI SANKYO COMPANY, LIMITED, Bio-Techne, REPROCELL Inc., Catalent, Inc, Mesoblast Ltd, Astellas Pharma Inc. among others.

The strategic initiatives by market players along with new technological advancements for stem cell manufacturing is bridging the gap for various treatments.

For instance,

  • In June 2021, REPROCELL Inc. announced that it has opened new seed iPSC manufacture suite to meet the increasing demand of Ipsc-derived master cell banks. This will help the company to address the rising demand and to grow in coming years.
  • In June 2021, Catalent Inc. announced that is has acquired RheinCell Therapeuics which is a  manufaxcturer of human induced pluripotent stem cells. This will help the company to build up the company’s existing custom cell herapy process development.
  • In June 2021, Bio-Techne announced that is has enhanced its gene engineering and cell and gene therapy manufacturing capability. This will help the company to further expand its business.

Collaboration, joint ventures, and other strategies by the market player is enhancing the company market in the stem cell manufacturing market, which also provides the benefit for the organization to improve their offering for stem cell manufacturing market.

Customization Available: Europe Stem Cell Manufacturing Market 

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report. 


SKU-

LIST OF TABLES 

TABLE 1 BELOW PROVIDED ARE THE ALTERNATIVES FOR CANCER TREATMENT:

TABLE 2 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)

TABLE 3 EUROPE STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 4 EUROPE CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 EUROPE CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 6 EUROPE STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 EUROPE STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 8 EUROPE HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 9 EUROPE PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 10 EUROPE RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 11 EUROPE INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 EUROPE INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 13 EUROPE STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 14 EUROPE RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 EUROPE RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 16 EUROPE CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 EUROPE CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 18 EUROPE ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 19 EUROPE AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 20 EUROPE CELL & TISSUE BANKING IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 EUROPE OTHERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 EUROPE STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 23 EUROPE BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 EUROPE RESEARCH INSTITUTES AND ACADEMIC INSTITUTES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 EUROPE CELL BANKS & TISSUE BANKS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 EUROPE HOSPITALS & SURGICAL CENTERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 EUROPE OTHERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 EUROPE STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 29 EUROPE DIRECT SALES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 EUROPE THIRD PARTY DISTRIBUTORS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 EUROPE STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 32 EUROPE STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 33 EUROPE CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 34 EUROPE STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 35 EUROPE HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 36 EUROPE PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 37 EUROPE RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 38 EUROPE INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 39 EUROPE STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 40 EUROPE RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 41 EUROPE CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 42 EUROPE ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 43 EUROPE AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 44 EUROPE STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 45 EUROPE STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 46 GERMANY STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 47 GERMANY CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 48 GERMANY STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 49 GERMANY HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 50 GERMANY PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 51 GERMANY RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 52 GERMANY INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 53 GERMANY STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 54 GERMANY RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 55 GERMANY CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 56 GERMANY ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 57 GERMANY AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 58 GERMANY STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 59 GERMANY STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 60 FRANCE STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 61 FRANCE CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 62 FRANCE STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 63 FRANCE HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 64 FRANCE PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 65 FRANCE RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 66 FRANCE INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 67 FRANCE STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 68 FRANCE RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 69 FRANCE CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 70 FRANCE ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 71 FRANCE AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 72 FRANCE STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 73 FRANCE STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 74 U.K. STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 75 U.K. CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 76 U.K. STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 77 U.K. HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 78 U.K. PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 79 U.K. RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 80 U.K. INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 81 U.K. STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 82 U.K. RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 83 U.K. CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 84 U.K. ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 85 U.K. AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 86 U.K. STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 87 U.K. STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 88 ITALY STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 89 ITALY CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 90 ITALY STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 91 ITALY HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 92 ITALY PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 93 ITALY RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 94 ITALY INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 95 ITALY STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 96 ITALY RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 97 ITALY CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 98 ITALY ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 99 ITALY AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 100 ITALY STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 101 ITALY STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 102 NETHERLAND STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 103 NETHERLAND CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 104 NETHERLAND STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 105 NETHERLAND HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 106 NETHERLAND PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 107 NETHERLAND RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 108 NETHERLAND INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 109 NETHERLAND STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 110 NETHERLAND RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 111 NETHERLAND CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 112 NETHERLAND ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 113 NETHERLAND AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 114 NETHERLAND STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 115 NETHERLAND STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 116 SWITZERLAND STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 117 SWITZERLAND CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 118 SWITZERLAND STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 119 SWITZERLAND HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 120 SWITZERLAND PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 121 SWITZERLAND RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 122 SWITZERLAND INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 123 SWITZERLAND STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 124 SWITZERLAND RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 125 SWITZERLAND CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 126 SWITZERLAND ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 127 SWITZERLAND AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 128 SWITZERLAND STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 129 SWITZERLAND STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 130 SPAIN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 131 SPAIN CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 132 SPAIN STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 133 SPAIN HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 134 SPAIN PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 135 SPAIN RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 136 SPAINSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 137 SPAIN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 138 SPAIN RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 139 SPAIN CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 140 SPAIN ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 141 SPAIN AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 142 SPAIN STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 143 SPAIN STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 144 RUSSIA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 145 RUSSIA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 146 RUSSIA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 147 RUSSIA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 148 RUSSIA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 149 RUSSIA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 150 RUSSIA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 151 RUSSIA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 152 RUSSIA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 153 RUSSIA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 154 RUSSIA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 155 RUSSIA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 156 RUSSIA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 157 RUSSIA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 158 BELGIUM STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 159 BELGIUM CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 160 BELGIUM STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 161 BELGIUM HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 162 BELGIUM PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 163 BELGIUM RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 164 BELGIUM INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 165 BELGIUM STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 166 BELGIUM RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 167 BELGIUM CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 168 BELGIUM ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 169 BELGIUM AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 170 BELGIUM STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 171 BELGIUM STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 172 TURKEY STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 173 TURKEY CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 174 TURKEY STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 175 TURKEY HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 176 TURKEY PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 177 TURKEY RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 178 TURKEY INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 179 TURKEY STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 180 TURKEY RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 181 TURKEY CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 182 TURKEY ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 183 TURKEY AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 184 TURKEY STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 185 TURKEY STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 186 REST OF EUROPE STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions